• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从 sp. ZHD001 的活性粗提物中鉴定出具有降脂活性的新型螺氢呋喃衍生化合物。

Identification of Novel Sphydrofuran-Derived Derivatives with Lipid-Lowering Activity from the Active Crude Extracts of sp. ZHD001.

机构信息

School of Food and Pharmacy, Zhejiang Ocean University, Zhoushan 316022, China.

Institute of Marine Biology and Pharmacology, Ocean College, Zhejiang University, Zhoushan 316021, China.

出版信息

Int J Mol Sci. 2023 Feb 1;24(3):2822. doi: 10.3390/ijms24032822.

DOI:10.3390/ijms24032822
PMID:36769145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9917766/
Abstract

Lipid-lowering is one of the most effective methods of prevention and treatment for cardiovascular diseases. However, most clinical lipid-lowering drugs have adverse effects and cannot achieve the desired efficacy in some complex hyperlipidemia patients, so it is of great significance to develop safe and effective novel lipid-lowering drugs. In the course of our project aimed at discovering the chemical novelty and bioactive natural products of marine-derived actinomycetes, we found that the organic crude extracts (OCEs) of sp. ZHD001 exhibited strong in vivo efficacies in reducing weight gain, lowering LDL-C, TC, and TG levels, and improving HDL-C levels in high-fat-diet-fed mice models. Chemical investigations of the active OCEs led to identifying two new sphydrofuran-derived compounds (-) and one known 2-methyl-4-(1-glycerol)-furan (). Their structures were elucidated by the analysis of HRESIMS, 1D and 2D NMR spectroscopic data, and ECD calculations. Among these compounds, compound represents a novel rearranged sphydrofuran-derived derivative. Bioactivity evaluations of these pure compounds showed that all the compounds exhibited significant lipid-lowering activity with lower cytotoxicity in vitro compared to simvastatin. Our results demonstrate that sphydrofuran-derived derivatives might be promising candidates for lipid-lowering drugs.

摘要

降脂是预防和治疗心血管疾病最有效的方法之一。然而,大多数临床降脂药物都有不良反应,并且在一些复杂的高脂血症患者中无法达到预期的疗效,因此开发安全有效的新型降脂药物具有重要意义。在我们旨在发现海洋放线菌中具有化学新颖性和生物活性的天然产物的项目过程中,我们发现 sp. ZHD001 的有机粗提取物 (OCEs) 在降低高脂饮食喂养的小鼠模型体重增加、降低 LDL-C、TC 和 TG 水平以及提高 HDL-C 水平方面表现出很强的体内疗效。对活性 OCEs 的化学研究导致鉴定出两种新的 sp 氢呋喃衍生化合物 (-) 和一种已知的 2-甲基-4-(1-甘油基)-呋喃 ()。通过分析 HRESIMS、1D 和 2D NMR 光谱数据和 ECD 计算,阐明了它们的结构。在这些化合物中,化合物代表一种新型的重排 sp 氢呋喃衍生衍生物。这些纯化合物的活性评估表明,与辛伐他汀相比,所有化合物在体外均表现出显著的降脂活性和更低的细胞毒性。我们的结果表明,sp 氢呋喃衍生衍生物可能是有前途的降脂药物候选物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8df/9917766/88a3922a1454/ijms-24-02822-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8df/9917766/fe9439bdf4e2/ijms-24-02822-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8df/9917766/55cd3423d1c9/ijms-24-02822-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8df/9917766/8ffacf2c4772/ijms-24-02822-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8df/9917766/b36c71f9a2be/ijms-24-02822-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8df/9917766/3ca3d4053867/ijms-24-02822-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8df/9917766/54a78812d0d9/ijms-24-02822-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8df/9917766/88a3922a1454/ijms-24-02822-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8df/9917766/fe9439bdf4e2/ijms-24-02822-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8df/9917766/55cd3423d1c9/ijms-24-02822-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8df/9917766/8ffacf2c4772/ijms-24-02822-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8df/9917766/b36c71f9a2be/ijms-24-02822-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8df/9917766/3ca3d4053867/ijms-24-02822-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8df/9917766/54a78812d0d9/ijms-24-02822-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8df/9917766/88a3922a1454/ijms-24-02822-g007.jpg

相似文献

1
Identification of Novel Sphydrofuran-Derived Derivatives with Lipid-Lowering Activity from the Active Crude Extracts of sp. ZHD001.从 sp. ZHD001 的活性粗提物中鉴定出具有降脂活性的新型螺氢呋喃衍生化合物。
Int J Mol Sci. 2023 Feb 1;24(3):2822. doi: 10.3390/ijms24032822.
2
Bioactivity-guided fractionation of the triglyceride-lowering component and in vivo and in vitro evaluation of hypolipidemic effects of Calyx seu Fructus Physalis.生物活性导向的降脂成分的分段分离及其体内外对酸浆果实降脂作用的评价。
Lipids Health Dis. 2012 Mar 14;11:38. doi: 10.1186/1476-511X-11-38.
3
Cytotoxic activity of actinomycetes sp. and s sp. associated with marine sponge sp.与海洋海绵物种相关的放线菌属物种和链霉菌属物种的细胞毒性活性
Nat Prod Res. 2022 Jun;36(11):2917-2922. doi: 10.1080/14786419.2021.1931865. Epub 2021 May 27.
4
Targeted isolation and identification of bioactive compounds lowering cholesterol in the crude extracts of crabapples using UPLC-DAD-MS-SPE/NMR based on pharmacology-guided PLS-DA.基于药理导向的偏最小二乘判别分析,采用超高效液相色谱-二极管阵列检测-质谱联用-固相萃取/核磁共振技术,对海棠粗提物中降低胆固醇的生物活性化合物进行靶向分离与鉴定。
J Pharm Biomed Anal. 2018 Feb 20;150:144-151. doi: 10.1016/j.jpba.2017.11.061. Epub 2017 Dec 2.
5
The metabolic change of serum lysophosphatidylcholines involved in the lipid lowering effect of triterpenes from Alismatis rhizoma on high-fat diet induced hyperlipidemia mice.泽泻三萜类化合物对高脂饮食诱导的高脂血症小鼠降脂作用中血清溶血磷脂酰胆碱的代谢变化。
J Ethnopharmacol. 2016 Jan 11;177:10-8. doi: 10.1016/j.jep.2015.11.017. Epub 2015 Nov 14.
6
New Pyrroline Isolated from Antarctic Krill-Derived Actinomycetes sp. LX-1 Combining with Molecular Networking.南极磷虾来源放线菌 LX-1 中新吡咯烷的分离与分子网络组合。
Mar Drugs. 2023 Feb 15;21(2):127. doi: 10.3390/md21020127.
7
Long-term prognostic value of LDL-C, HDL-C, lp(a) and TG levels on cardiovascular disease incidence, by body weight status, dietary habits and lipid-lowering treatment: the ATTICA epidemiological cohort study (2002-2012).按体重状况、饮食习惯和降脂治疗划分的 LDL-C、HDL-C、lp(a) 和 TG 水平对心血管疾病发病的长期预后价值:ATTICA 流行病学队列研究(2002-2012 年)。
Lipids Health Dis. 2022 Dec 19;21(1):141. doi: 10.1186/s12944-022-01747-2.
8
Genus : A Prolific Producer of Natural Products.属:天然产物的多产生产者。
Mar Drugs. 2022 May 31;20(6):374. doi: 10.3390/md20060374.
9
Cholesterol-lowering effects and potential mechanisms of different polar extracts from Cyclocarya paliurus leave in hyperlipidemic mice.不同极性萃取物对高脂血症小鼠降脂作用及潜在机制的研究
J Ethnopharmacol. 2015 Dec 24;176:17-26. doi: 10.1016/j.jep.2015.10.006. Epub 2015 Oct 23.
10
Isolation and characterization of bioactive compounds with antibacterial, antioxidant and enzyme inhibitory activities from marine-derived rare actinobacteria, Nocardiopsis sp. SCA21.从海洋来源稀有放线菌,诺卡氏菌属 SCA21 中分离和鉴定具有抗菌、抗氧化和酶抑制活性的生物活性化合物。
Microb Pathog. 2019 Dec;137:103775. doi: 10.1016/j.micpath.2019.103775. Epub 2019 Oct 7.

引用本文的文献

1
Non-Steroidal FXR Agonistic Dimeric 2-Methyl-4-(1-glycerol)furan with Lipid-Lowering Activities from Marine-Derived sp. ZSN1.具有降脂活性的非甾体类法尼醇X受体激动剂二聚体2-甲基-4-(1-甘油基)呋喃,来源于海洋源sp. ZSN1。
Mar Drugs. 2025 Feb 20;23(3):92. doi: 10.3390/md23030092.

本文引用的文献

1
Marine natural products as source of new drugs: an updated patent review (July 2018-July 2021).海洋天然产物作为新药来源:专利更新综述(2018 年 7 月至 2021 年 7 月)。
Expert Opin Ther Pat. 2022 Mar;32(3):317-363. doi: 10.1080/13543776.2022.2012150. Epub 2022 Jan 5.
2
Global epidemiology of dyslipidaemias.血脂异常的全球流行病学。
Nat Rev Cardiol. 2021 Oct;18(10):689-700. doi: 10.1038/s41569-021-00541-4. Epub 2021 Apr 8.
3
Actinobacteria in natural products research: Progress and prospects.天然产物研究中的放线菌:进展与展望。
Microbiol Res. 2021 May;246:126708. doi: 10.1016/j.micres.2021.126708. Epub 2021 Jan 22.
4
Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.心脏病与中风统计-2021 更新:美国心脏协会报告。
Circulation. 2021 Feb 23;143(8):e254-e743. doi: 10.1161/CIR.0000000000000950. Epub 2021 Jan 27.
5
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study.全球心血管疾病负担及危险因素, 1990-2019:来自 GBD 2019 研究的更新。
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021. doi: 10.1016/j.jacc.2020.11.010.
6
A new indolizinium alkaloid from marine-derived sp. HNA39.海洋来源的 sp. HNA39 中一种新的吲哚里西啶生物碱。
J Asian Nat Prod Res. 2021 Sep;23(9):913-918. doi: 10.1080/10286020.2020.1799987. Epub 2020 Aug 21.
7
Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease.用于预防动脉粥样硬化性心血管疾病的血脂管理
N Engl J Med. 2019 Oct 17;381(16):1557-1567. doi: 10.1056/NEJMra1806939.
8
Epidemiology of cardiovascular disease in China: current features and implications.中国心血管疾病的流行病学:现状特征及影响。
Nat Rev Cardiol. 2019 Apr;16(4):203-212. doi: 10.1038/s41569-018-0119-4.
9
Medermycin-Type Naphthoquinones from the Marine-Derived Streptomyces sp. XMA39.海洋来源链霉菌 XMA39 中产生的美登素型萘醌类化合物。
J Nat Prod. 2018 Sep 28;81(9):2120-2124. doi: 10.1021/acs.jnatprod.8b00544. Epub 2018 Sep 13.
10
Cyclizidine-Type Alkaloids from Streptomyces sp. HNA39.链霉菌属 HNA39 中的金纽扣烷型生物碱。
J Nat Prod. 2018 Feb 23;81(2):394-399. doi: 10.1021/acs.jnatprod.7b01055. Epub 2018 Feb 1.